nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—SSTR2—kidney—systemic lupus erythematosus	0.0126	0.153	CbGeAlD
Pasireotide—SSTR3—nervous system—systemic lupus erythematosus	0.0123	0.149	CbGeAlD
Pasireotide—SSTR3—central nervous system—systemic lupus erythematosus	0.0119	0.143	CbGeAlD
Pasireotide—SSTR1—lung—systemic lupus erythematosus	0.0105	0.127	CbGeAlD
Pasireotide—SSTR1—nervous system—systemic lupus erythematosus	0.00976	0.118	CbGeAlD
Pasireotide—SSTR1—central nervous system—systemic lupus erythematosus	0.00939	0.113	CbGeAlD
Pasireotide—SSTR2—nervous system—systemic lupus erythematosus	0.0083	0.1	CbGeAlD
Pasireotide—SSTR2—central nervous system—systemic lupus erythematosus	0.00799	0.0964	CbGeAlD
Pasireotide—Aspartate aminotransferase increased—Mycophenolate mofetil—systemic lupus erythematosus	0.00273	0.00489	CcSEcCtD
Pasireotide—Diabetes mellitus—Betamethasone—systemic lupus erythematosus	0.00272	0.00486	CcSEcCtD
Pasireotide—Diabetes mellitus—Dexamethasone—systemic lupus erythematosus	0.00272	0.00486	CcSEcCtD
Pasireotide—Abdominal distension—Cyclosporine—systemic lupus erythematosus	0.00271	0.00484	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Mycophenolate mofetil—systemic lupus erythematosus	0.00268	0.00479	CcSEcCtD
Pasireotide—Abdominal distension—Mycophenolate mofetil—systemic lupus erythematosus	0.00264	0.00473	CcSEcCtD
Pasireotide—Influenza—Mycophenolate mofetil—systemic lupus erythematosus	0.00262	0.00469	CcSEcCtD
Pasireotide—Alopecia—Azathioprine—systemic lupus erythematosus	0.00261	0.00467	CcSEcCtD
Pasireotide—Dry skin—Prednisolone—systemic lupus erythematosus	0.00259	0.00464	CcSEcCtD
Pasireotide—Dry skin—Hydrocortisone—systemic lupus erythematosus	0.00253	0.00453	CcSEcCtD
Pasireotide—Abdominal pain upper—Hydrocortisone—systemic lupus erythematosus	0.00252	0.00452	CcSEcCtD
Pasireotide—Hypokalaemia—Hydrocortisone—systemic lupus erythematosus	0.00252	0.0045	CcSEcCtD
Pasireotide—Alopecia—Leflunomide—systemic lupus erythematosus	0.00246	0.00441	CcSEcCtD
Pasireotide—Abdominal distension—Prednisolone—systemic lupus erythematosus	0.00246	0.00441	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Hydrocortisone—systemic lupus erythematosus	0.00244	0.00436	CcSEcCtD
Pasireotide—Hyperglycaemia—Cyclosporine—systemic lupus erythematosus	0.00243	0.00434	CcSEcCtD
Pasireotide—Abdominal distension—Hydrocortisone—systemic lupus erythematosus	0.00241	0.0043	CcSEcCtD
Pasireotide—Anaemia—Azathioprine—systemic lupus erythematosus	0.00238	0.00425	CcSEcCtD
Pasireotide—Hyperglycaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.00237	0.00423	CcSEcCtD
Pasireotide—Diabetes mellitus—Prednisone—systemic lupus erythematosus	0.00236	0.00423	CcSEcCtD
Pasireotide—Vomiting—Dapsone—systemic lupus erythematosus	0.00236	0.00422	CcSEcCtD
Pasireotide—Back pain—Leflunomide—systemic lupus erythematosus	0.00235	0.0042	CcSEcCtD
Pasireotide—Headache—Dapsone—systemic lupus erythematosus	0.00232	0.00416	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Methylprednisolone—systemic lupus erythematosus	0.00229	0.0041	CcSEcCtD
Pasireotide—Abdominal distension—Triamcinolone—systemic lupus erythematosus	0.00226	0.00405	CcSEcCtD
Pasireotide—Abdominal distension—Methylprednisolone—systemic lupus erythematosus	0.00226	0.00404	CcSEcCtD
Pasireotide—Influenza—Triamcinolone—systemic lupus erythematosus	0.00225	0.00403	CcSEcCtD
Pasireotide—Anaemia—Leflunomide—systemic lupus erythematosus	0.00224	0.00402	CcSEcCtD
Pasireotide—Nausea—Dapsone—systemic lupus erythematosus	0.0022	0.00394	CcSEcCtD
Pasireotide—Arthralgia—Azathioprine—systemic lupus erythematosus	0.00219	0.00392	CcSEcCtD
Pasireotide—Myalgia—Azathioprine—systemic lupus erythematosus	0.00219	0.00392	CcSEcCtD
Pasireotide—Vertigo—Leflunomide—systemic lupus erythematosus	0.00218	0.0039	CcSEcCtD
Pasireotide—Dry skin—Dexamethasone—systemic lupus erythematosus	0.00216	0.00387	CcSEcCtD
Pasireotide—Dry skin—Betamethasone—systemic lupus erythematosus	0.00216	0.00387	CcSEcCtD
Pasireotide—Hypokalaemia—Betamethasone—systemic lupus erythematosus	0.00215	0.00385	CcSEcCtD
Pasireotide—Hypokalaemia—Dexamethasone—systemic lupus erythematosus	0.00215	0.00385	CcSEcCtD
Pasireotide—Hypertension—Leflunomide—systemic lupus erythematosus	0.0021	0.00375	CcSEcCtD
Pasireotide—Oedema peripheral—Mycophenolate mofetil—systemic lupus erythematosus	0.00207	0.0037	CcSEcCtD
Pasireotide—Myalgia—Leflunomide—systemic lupus erythematosus	0.00207	0.0037	CcSEcCtD
Pasireotide—Arthralgia—Leflunomide—systemic lupus erythematosus	0.00207	0.0037	CcSEcCtD
Pasireotide—Anxiety—Leflunomide—systemic lupus erythematosus	0.00206	0.00369	CcSEcCtD
Pasireotide—Diabetes mellitus—Methotrexate—systemic lupus erythematosus	0.00198	0.00354	CcSEcCtD
Pasireotide—Hypotension—Azathioprine—systemic lupus erythematosus	0.00196	0.00351	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Azathioprine—systemic lupus erythematosus	0.00191	0.00342	CcSEcCtD
Pasireotide—Alopecia—Cyclosporine—systemic lupus erythematosus	0.0019	0.0034	CcSEcCtD
Pasireotide—Dry skin—Prednisone—systemic lupus erythematosus	0.00189	0.00337	CcSEcCtD
Pasireotide—Hypokalaemia—Prednisone—systemic lupus erythematosus	0.00187	0.00335	CcSEcCtD
Pasireotide—Alopecia—Mycophenolate mofetil—systemic lupus erythematosus	0.00185	0.00332	CcSEcCtD
Pasireotide—Hypotension—Leflunomide—systemic lupus erythematosus	0.00185	0.00331	CcSEcCtD
Pasireotide—Hyperglycaemia—Dexamethasone—systemic lupus erythematosus	0.00184	0.0033	CcSEcCtD
Pasireotide—Hyperglycaemia—Betamethasone—systemic lupus erythematosus	0.00184	0.0033	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Prednisone—systemic lupus erythematosus	0.00181	0.00325	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Leflunomide—systemic lupus erythematosus	0.0018	0.00323	CcSEcCtD
Pasireotide—Insomnia—Leflunomide—systemic lupus erythematosus	0.00179	0.00321	CcSEcCtD
Pasireotide—SSTR1—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.00179	0.00499	CbGpPWpGaD
Pasireotide—Abdominal distension—Prednisone—systemic lupus erythematosus	0.00179	0.0032	CcSEcCtD
Pasireotide—SSTR5—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.00178	0.00497	CbGpPWpGaD
Pasireotide—Back pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00177	0.00316	CcSEcCtD
Pasireotide—SSTR5—G alpha (i) signalling events—CCR5—systemic lupus erythematosus	0.00175	0.00489	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.00174	0.00487	CbGpPWpGaD
Pasireotide—Anaemia—Cyclosporine—systemic lupus erythematosus	0.00173	0.0031	CcSEcCtD
Pasireotide—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.00172	0.00308	CcSEcCtD
Pasireotide—Gastrointestinal pain—Azathioprine—systemic lupus erythematosus	0.00172	0.00307	CcSEcCtD
Pasireotide—SSTR5—G alpha (i) signalling events—C3—systemic lupus erythematosus	0.00171	0.00477	CbGpPWpGaD
Pasireotide—Fatigue—Leflunomide—systemic lupus erythematosus	0.00171	0.00306	CcSEcCtD
Pasireotide—Constipation—Leflunomide—systemic lupus erythematosus	0.00169	0.00303	CcSEcCtD
Pasireotide—Anaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.00169	0.00302	CcSEcCtD
Pasireotide—Vertigo—Cyclosporine—systemic lupus erythematosus	0.00168	0.00301	CcSEcCtD
Pasireotide—Abdominal pain—Azathioprine—systemic lupus erythematosus	0.00166	0.00297	CcSEcCtD
Pasireotide—SSTR2—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.00164	0.00459	CbGpPWpGaD
Pasireotide—Vertigo—Mycophenolate mofetil—systemic lupus erythematosus	0.00164	0.00294	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.00164	0.00457	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.00163	0.00453	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Leflunomide—systemic lupus erythematosus	0.00162	0.0029	CcSEcCtD
Pasireotide—Hypertension—Cyclosporine—systemic lupus erythematosus	0.00162	0.00289	CcSEcCtD
Pasireotide—SSTR2—G alpha (i) signalling events—CCR5—systemic lupus erythematosus	0.00162	0.00451	CbGpPWpGaD
Pasireotide—Hyperglycaemia—Prednisone—systemic lupus erythematosus	0.0016	0.00287	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.0016	0.00447	CbGpPWpGaD
Pasireotide—Arthralgia—Cyclosporine—systemic lupus erythematosus	0.00159	0.00285	CcSEcCtD
Pasireotide—Myalgia—Cyclosporine—systemic lupus erythematosus	0.00159	0.00285	CcSEcCtD
Pasireotide—Anxiety—Cyclosporine—systemic lupus erythematosus	0.00159	0.00284	CcSEcCtD
Pasireotide—SSTR5—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.00159	0.00443	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—C3—systemic lupus erythematosus	0.00158	0.00441	CbGpPWpGaD
Pasireotide—Hypertension—Mycophenolate mofetil—systemic lupus erythematosus	0.00158	0.00282	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.00157	0.00438	CbGpPWpGaD
Pasireotide—Abdominal pain—Leflunomide—systemic lupus erythematosus	0.00157	0.0028	CcSEcCtD
Pasireotide—Arthralgia—Mycophenolate mofetil—systemic lupus erythematosus	0.00156	0.00278	CcSEcCtD
Pasireotide—Myalgia—Mycophenolate mofetil—systemic lupus erythematosus	0.00156	0.00278	CcSEcCtD
Pasireotide—Anxiety—Mycophenolate mofetil—systemic lupus erythematosus	0.00155	0.00277	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.00155	0.00432	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.00153	0.00428	CbGpPWpGaD
Pasireotide—Vertigo—Prednisolone—systemic lupus erythematosus	0.00153	0.00274	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.00153	0.00426	CbGpPWpGaD
Pasireotide—Back pain—Triamcinolone—systemic lupus erythematosus	0.00152	0.00271	CcSEcCtD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.0015	0.00418	CbGpPWpGaD
Pasireotide—Vertigo—Hydrocortisone—systemic lupus erythematosus	0.0015	0.00268	CcSEcCtD
Pasireotide—Hypertension—Prednisolone—systemic lupus erythematosus	0.00147	0.00263	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.00147	0.00409	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.00147	0.00409	CbGpPWpGaD
Pasireotide—Alopecia—Betamethasone—systemic lupus erythematosus	0.00144	0.00258	CcSEcCtD
Pasireotide—Alopecia—Dexamethasone—systemic lupus erythematosus	0.00144	0.00258	CcSEcCtD
Pasireotide—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.00144	0.00257	CcSEcCtD
Pasireotide—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.00144	0.00257	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.00143	0.00398	CbGpPWpGaD
Pasireotide—Asthenia—Leflunomide—systemic lupus erythematosus	0.00142	0.00254	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	0.00142	0.00396	CbGpPWpGaD
Pasireotide—Myalgia—Hydrocortisone—systemic lupus erythematosus	0.00142	0.00254	CcSEcCtD
Pasireotide—Anxiety—Hydrocortisone—systemic lupus erythematosus	0.00141	0.00253	CcSEcCtD
Pasireotide—Vertigo—Triamcinolone—systemic lupus erythematosus	0.00141	0.00252	CcSEcCtD
Pasireotide—Vertigo—Methylprednisolone—systemic lupus erythematosus	0.00141	0.00251	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.00141	0.00392	CbGpPWpGaD
Pasireotide—Pruritus—Leflunomide—systemic lupus erythematosus	0.0014	0.00251	CcSEcCtD
Pasireotide—Hypotension—Mycophenolate mofetil—systemic lupus erythematosus	0.00139	0.00249	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	0.00139	0.00249	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.00139	0.00389	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.00139	0.00387	CbGpPWpGaD
Pasireotide—Dizziness—Azathioprine—systemic lupus erythematosus	0.00139	0.00248	CcSEcCtD
Pasireotide—Insomnia—Cyclosporine—systemic lupus erythematosus	0.00138	0.00247	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.00136	0.0038	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.00136	0.00243	CcSEcCtD
Pasireotide—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.00136	0.00243	CcSEcCtD
Pasireotide—Hypertension—Triamcinolone—systemic lupus erythematosus	0.00135	0.00242	CcSEcCtD
Pasireotide—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.00135	0.00242	CcSEcCtD
Pasireotide—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.00135	0.00241	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.00135	0.00376	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	0.00135	0.00375	CbGpPWpGaD
Pasireotide—Myalgia—Triamcinolone—systemic lupus erythematosus	0.00133	0.00239	CcSEcCtD
Pasireotide—Vomiting—Azathioprine—systemic lupus erythematosus	0.00133	0.00239	CcSEcCtD
Pasireotide—Myalgia—Methylprednisolone—systemic lupus erythematosus	0.00133	0.00238	CcSEcCtD
Pasireotide—Arthralgia—Methylprednisolone—systemic lupus erythematosus	0.00133	0.00238	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.00133	0.00371	CbGpPWpGaD
Pasireotide—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.00133	0.00238	CcSEcCtD
Pasireotide—Anxiety—Methylprednisolone—systemic lupus erythematosus	0.00133	0.00237	CcSEcCtD
Pasireotide—Fatigue—Cyclosporine—systemic lupus erythematosus	0.00132	0.00236	CcSEcCtD
Pasireotide—Headache—Azathioprine—systemic lupus erythematosus	0.00131	0.00235	CcSEcCtD
Pasireotide—Dizziness—Leflunomide—systemic lupus erythematosus	0.00131	0.00234	CcSEcCtD
Pasireotide—Constipation—Cyclosporine—systemic lupus erythematosus	0.00131	0.00234	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.0013	0.00363	CbGpPWpGaD
Pasireotide—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.0013	0.00232	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.00129	0.00359	CbGpPWpGaD
Pasireotide—Vertigo—Betamethasone—systemic lupus erythematosus	0.00128	0.00229	CcSEcCtD
Pasireotide—Vertigo—Dexamethasone—systemic lupus erythematosus	0.00128	0.00229	CcSEcCtD
Pasireotide—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.00128	0.00228	CcSEcCtD
Pasireotide—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.00127	0.00227	CcSEcCtD
Pasireotide—Vomiting—Leflunomide—systemic lupus erythematosus	0.00126	0.00225	CcSEcCtD
Pasireotide—Insomnia—Prednisolone—systemic lupus erythematosus	0.00126	0.00225	CcSEcCtD
Pasireotide—Alopecia—Prednisone—systemic lupus erythematosus	0.00126	0.00225	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.00126	0.0035	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.00125	0.00349	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.00125	0.00224	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.00125	0.00348	CbGpPWpGaD
Pasireotide—Nausea—Azathioprine—systemic lupus erythematosus	0.00125	0.00223	CcSEcCtD
Pasireotide—Headache—Leflunomide—systemic lupus erythematosus	0.00124	0.00222	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.00124	0.00222	CcSEcCtD
Pasireotide—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.00123	0.0022	CcSEcCtD
Pasireotide—Hypertension—Dexamethasone—systemic lupus erythematosus	0.00123	0.0022	CcSEcCtD
Pasireotide—Hypertension—Betamethasone—systemic lupus erythematosus	0.00123	0.0022	CcSEcCtD
Pasireotide—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00122	0.00218	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—C3—systemic lupus erythematosus	0.00122	0.0034	CbGpPWpGaD
Pasireotide—Myalgia—Betamethasone—systemic lupus erythematosus	0.00121	0.00217	CcSEcCtD
Pasireotide—Myalgia—Dexamethasone—systemic lupus erythematosus	0.00121	0.00217	CcSEcCtD
Pasireotide—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.00121	0.00216	CcSEcCtD
Pasireotide—Anxiety—Betamethasone—systemic lupus erythematosus	0.00121	0.00216	CcSEcCtD
Pasireotide—Anxiety—Dexamethasone—systemic lupus erythematosus	0.00121	0.00216	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.0012	0.00335	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.0012	0.00335	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.0012	0.00334	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.00119	0.00333	CbGpPWpGaD
Pasireotide—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.00119	0.00213	CcSEcCtD
Pasireotide—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.00118	0.00211	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.00118	0.00329	CbGpPWpGaD
Pasireotide—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00118	0.00211	CcSEcCtD
Pasireotide—Nausea—Leflunomide—systemic lupus erythematosus	0.00118	0.00211	CcSEcCtD
Pasireotide—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.00117	0.0021	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—C3—systemic lupus erythematosus	0.00117	0.00326	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.00117	0.00209	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.00116	0.00208	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	0.00116	0.00324	CbGpPWpGaD
Pasireotide—Insomnia—Triamcinolone—systemic lupus erythematosus	0.00116	0.00207	CcSEcCtD
Pasireotide—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.00115	0.00207	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	0.00115	0.00322	CbGpPWpGaD
Pasireotide—Anaemia—Prednisone—systemic lupus erythematosus	0.00114	0.00205	CcSEcCtD
Pasireotide—Vertigo—Prednisone—systemic lupus erythematosus	0.00111	0.00199	CcSEcCtD
Pasireotide—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.00111	0.00199	CcSEcCtD
Pasireotide—Fatigue—Triamcinolone—systemic lupus erythematosus	0.0011	0.00197	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.0011	0.00308	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	0.0011	0.00307	CbGpPWpGaD
Pasireotide—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.0011	0.00197	CcSEcCtD
Pasireotide—Asthenia—Cyclosporine—systemic lupus erythematosus	0.0011	0.00196	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.00109	0.00304	CbGpPWpGaD
Pasireotide—Hypotension—Betamethasone—systemic lupus erythematosus	0.00108	0.00194	CcSEcCtD
Pasireotide—Hypotension—Dexamethasone—systemic lupus erythematosus	0.00108	0.00194	CcSEcCtD
Pasireotide—Pruritus—Cyclosporine—systemic lupus erythematosus	0.00108	0.00194	CcSEcCtD
Pasireotide—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.00107	0.00192	CcSEcCtD
Pasireotide—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.00107	0.00192	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—F2—systemic lupus erythematosus	0.00107	0.00299	CbGpPWpGaD
Pasireotide—Hypertension—Prednisone—systemic lupus erythematosus	0.00107	0.00191	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.00106	0.00297	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.00106	0.00296	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.00106	0.00189	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.00106	0.00189	CcSEcCtD
Pasireotide—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.00106	0.00189	CcSEcCtD
Pasireotide—Myalgia—Prednisone—systemic lupus erythematosus	0.00105	0.00189	CcSEcCtD
Pasireotide—Arthralgia—Prednisone—systemic lupus erythematosus	0.00105	0.00189	CcSEcCtD
Pasireotide—Anxiety—Prednisone—systemic lupus erythematosus	0.00105	0.00188	CcSEcCtD
Pasireotide—Alopecia—Methotrexate—systemic lupus erythematosus	0.00105	0.00188	CcSEcCtD
Pasireotide—Insomnia—Dexamethasone—systemic lupus erythematosus	0.00105	0.00188	CcSEcCtD
Pasireotide—Insomnia—Betamethasone—systemic lupus erythematosus	0.00105	0.00188	CcSEcCtD
Pasireotide—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.00105	0.00187	CcSEcCtD
Pasireotide—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.00104	0.00187	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—C3—systemic lupus erythematosus	0.00104	0.00289	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.00103	0.00287	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—F2—systemic lupus erythematosus	0.00103	0.00286	CbGpPWpGaD
Pasireotide—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.00102	0.00183	CcSEcCtD
Pasireotide—Dizziness—Cyclosporine—systemic lupus erythematosus	0.00101	0.00181	CcSEcCtD
Pasireotide—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.00101	0.00181	CcSEcCtD
Pasireotide—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.00101	0.00181	CcSEcCtD
Pasireotide—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.00101	0.00181	CcSEcCtD
Pasireotide—Back pain—Methotrexate—systemic lupus erythematosus	0.001	0.00179	CcSEcCtD
Pasireotide—Fatigue—Dexamethasone—systemic lupus erythematosus	0.001	0.00179	CcSEcCtD
Pasireotide—Fatigue—Betamethasone—systemic lupus erythematosus	0.001	0.00179	CcSEcCtD
Pasireotide—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000986	0.00177	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000986	0.00275	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000983	0.00274	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.000979	0.00273	CbGpPWpGaD
Pasireotide—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000975	0.00174	CcSEcCtD
Pasireotide—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000972	0.00174	CcSEcCtD
Pasireotide—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000961	0.00172	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000959	0.00268	CbGpPWpGaD
Pasireotide—Headache—Cyclosporine—systemic lupus erythematosus	0.000958	0.00171	CcSEcCtD
Pasireotide—Anaemia—Methotrexate—systemic lupus erythematosus	0.000957	0.00171	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—C3—systemic lupus erythematosus	0.000956	0.00267	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000954	0.00266	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000949	0.0017	CcSEcCtD
Pasireotide—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000949	0.0017	CcSEcCtD
Pasireotide—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000948	0.0017	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	0.000944	0.00263	CbGpPWpGaD
Pasireotide—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000934	0.00167	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000934	0.00261	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	0.000931	0.0026	CbGpPWpGaD
Pasireotide—Vertigo—Methotrexate—systemic lupus erythematosus	0.00093	0.00166	CcSEcCtD
Pasireotide—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.00093	0.00166	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000921	0.00165	CcSEcCtD
Pasireotide—Dizziness—Prednisolone—systemic lupus erythematosus	0.00092	0.00165	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000919	0.00257	CbGpPWpGaD
Pasireotide—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000918	0.00164	CcSEcCtD
Pasireotide—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000918	0.00164	CcSEcCtD
Pasireotide—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000918	0.00164	CcSEcCtD
Pasireotide—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000916	0.00164	CcSEcCtD
Pasireotide—Insomnia—Prednisone—systemic lupus erythematosus	0.000914	0.00164	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000914	0.00255	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—F2—systemic lupus erythematosus	0.00091	0.00254	CbGpPWpGaD
Pasireotide—Nausea—Cyclosporine—systemic lupus erythematosus	0.000908	0.00163	CcSEcCtD
Pasireotide—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000905	0.00162	CcSEcCtD
Pasireotide—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000903	0.00162	CcSEcCtD
Pasireotide—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000898	0.00161	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000895	0.0025	CbGpPWpGaD
Pasireotide—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000886	0.00159	CcSEcCtD
Pasireotide—Myalgia—Methotrexate—systemic lupus erythematosus	0.000881	0.00158	CcSEcCtD
Pasireotide—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000881	0.00158	CcSEcCtD
Pasireotide—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000879	0.00157	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000874	0.00244	CbGpPWpGaD
Pasireotide—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000873	0.00156	CcSEcCtD
Pasireotide—Fatigue—Prednisone—systemic lupus erythematosus	0.000872	0.00156	CcSEcCtD
Pasireotide—Headache—Prednisolone—systemic lupus erythematosus	0.000872	0.00156	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000871	0.00243	CbGpPWpGaD
Pasireotide—Constipation—Prednisone—systemic lupus erythematosus	0.000864	0.00155	CcSEcCtD
Pasireotide—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000864	0.00155	CcSEcCtD
Pasireotide—Headache—Hydrocortisone—systemic lupus erythematosus	0.000851	0.00152	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000846	0.00236	CbGpPWpGaD
Pasireotide—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000846	0.00151	CcSEcCtD
Pasireotide—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000844	0.00151	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—F2—systemic lupus erythematosus	0.00084	0.00234	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000835	0.00233	CbGpPWpGaD
Pasireotide—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000833	0.00149	CcSEcCtD
Pasireotide—Asthenia—Betamethasone—systemic lupus erythematosus	0.000833	0.00149	CcSEcCtD
Pasireotide—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000827	0.00148	CcSEcCtD
Pasireotide—Nausea—Prednisolone—systemic lupus erythematosus	0.000826	0.00148	CcSEcCtD
Pasireotide—Pruritus—Betamethasone—systemic lupus erythematosus	0.000821	0.00147	CcSEcCtD
Pasireotide—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000821	0.00147	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.00082	0.00229	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000815	0.00228	CbGpPWpGaD
Pasireotide—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000813	0.00146	CcSEcCtD
Pasireotide—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000812	0.00145	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000811	0.00226	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000811	0.00226	CbGpPWpGaD
Pasireotide—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000807	0.00144	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000807	0.00225	CbGpPWpGaD
Pasireotide—Headache—Triamcinolone—systemic lupus erythematosus	0.000801	0.00143	CcSEcCtD
Pasireotide—Headache—Methylprednisolone—systemic lupus erythematosus	0.0008	0.00143	CcSEcCtD
Pasireotide—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000799	0.00143	CcSEcCtD
Pasireotide—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000794	0.00142	CcSEcCtD
Pasireotide—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000794	0.00142	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000794	0.00222	CbGpPWpGaD
Pasireotide—Hypotension—Methotrexate—systemic lupus erythematosus	0.000789	0.00141	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000786	0.00219	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000774	0.00216	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.00077	0.00138	CcSEcCtD
Pasireotide—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000768	0.00137	CcSEcCtD
Pasireotide—Dizziness—Betamethasone—systemic lupus erythematosus	0.000768	0.00137	CcSEcCtD
Pasireotide—Insomnia—Methotrexate—systemic lupus erythematosus	0.000764	0.00137	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	0.000762	0.00213	CbGpPWpGaD
Pasireotide—Nausea—Triamcinolone—systemic lupus erythematosus	0.00076	0.00136	CcSEcCtD
Pasireotide—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000758	0.00136	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—CSK—systemic lupus erythematosus	0.000754	0.0021	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000753	0.0021	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000748	0.00209	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000744	0.00208	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000742	0.00207	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.00074	0.00207	CbGpPWpGaD
Pasireotide—Vomiting—Betamethasone—systemic lupus erythematosus	0.000738	0.00132	CcSEcCtD
Pasireotide—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000738	0.00132	CcSEcCtD
Pasireotide—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000734	0.00131	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000733	0.00204	CbGpPWpGaD
Pasireotide—Fatigue—Methotrexate—systemic lupus erythematosus	0.000728	0.0013	CcSEcCtD
Pasireotide—Headache—Betamethasone—systemic lupus erythematosus	0.000727	0.0013	CcSEcCtD
Pasireotide—Headache—Dexamethasone—systemic lupus erythematosus	0.000727	0.0013	CcSEcCtD
Pasireotide—Asthenia—Prednisone—systemic lupus erythematosus	0.000725	0.0013	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—CSK—systemic lupus erythematosus	0.000723	0.00202	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TLR9—systemic lupus erythematosus	0.00072	0.00201	CbGpPWpGaD
Pasireotide—Pruritus—Prednisone—systemic lupus erythematosus	0.000715	0.00128	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000713	0.00199	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.000705	0.00197	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000697	0.00194	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000695	0.00194	CbGpPWpGaD
Pasireotide—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000692	0.00124	CcSEcCtD
Pasireotide—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000691	0.00124	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—NCF2—systemic lupus erythematosus	0.00069	0.00193	CbGpPWpGaD
Pasireotide—Nausea—Betamethasone—systemic lupus erythematosus	0.00069	0.00123	CcSEcCtD
Pasireotide—Nausea—Dexamethasone—systemic lupus erythematosus	0.00069	0.00123	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—C3—systemic lupus erythematosus	0.000689	0.00192	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—LYN—systemic lupus erythematosus	0.000685	0.00191	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000683	0.00191	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.000676	0.00189	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.000675	0.00188	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000672	0.00188	CbGpPWpGaD
Pasireotide—Dizziness—Prednisone—systemic lupus erythematosus	0.000669	0.0012	CcSEcCtD
Pasireotide—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000668	0.0012	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000666	0.00186	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000664	0.00185	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000662	0.00185	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—C3—systemic lupus erythematosus	0.00066	0.00184	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000658	0.00184	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—LYN—systemic lupus erythematosus	0.000657	0.00183	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.000648	0.00181	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000645	0.0018	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000643	0.00179	CbGpPWpGaD
Pasireotide—Vomiting—Prednisone—systemic lupus erythematosus	0.000643	0.00115	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—CSK—systemic lupus erythematosus	0.000641	0.00179	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.00064	0.00179	CbGpPWpGaD
Pasireotide—Headache—Prednisone—systemic lupus erythematosus	0.000633	0.00113	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000632	0.00176	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.000631	0.00176	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—C3—systemic lupus erythematosus	0.000625	0.00174	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000614	0.00171	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000607	0.00169	CbGpPWpGaD
Pasireotide—Asthenia—Methotrexate—systemic lupus erythematosus	0.000606	0.00108	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.000605	0.00169	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—F2—systemic lupus erythematosus	0.000605	0.00169	CbGpPWpGaD
Pasireotide—Nausea—Prednisone—systemic lupus erythematosus	0.0006	0.00107	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—C3—systemic lupus erythematosus	0.0006	0.00167	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.000599	0.00167	CbGpPWpGaD
Pasireotide—Pruritus—Methotrexate—systemic lupus erythematosus	0.000598	0.00107	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—CSK—systemic lupus erythematosus	0.000592	0.00165	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000591	0.00165	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000587	0.00164	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—C3—systemic lupus erythematosus	0.000586	0.00163	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000584	0.00163	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—LYN—systemic lupus erythematosus	0.000583	0.00163	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—F2—systemic lupus erythematosus	0.00058	0.00162	CbGpPWpGaD
Pasireotide—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000578	0.00103	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.000574	0.0016	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000572	0.0016	CbGpPWpGaD
Pasireotide—Dizziness—Methotrexate—systemic lupus erythematosus	0.000559	0.001	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.000553	0.00154	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000552	0.00154	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—F2—systemic lupus erythematosus	0.000549	0.00153	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000545	0.00152	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000544	0.00152	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000541	0.00151	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000541	0.00151	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—C3—systemic lupus erythematosus	0.00054	0.00151	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—LYN—systemic lupus erythematosus	0.000538	0.0015	CbGpPWpGaD
Pasireotide—Vomiting—Methotrexate—systemic lupus erythematosus	0.000537	0.000961	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.000536	0.0015	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—C3—systemic lupus erythematosus	0.000532	0.00148	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.00053	0.00148	CbGpPWpGaD
Pasireotide—Headache—Methotrexate—systemic lupus erythematosus	0.000529	0.000947	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000529	0.00148	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000528	0.00147	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—F2—systemic lupus erythematosus	0.000526	0.00147	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000519	0.00145	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000514	0.00144	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—F2—systemic lupus erythematosus	0.000514	0.00143	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000502	0.0014	CbGpPWpGaD
Pasireotide—Nausea—Methotrexate—systemic lupus erythematosus	0.000502	0.000898	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—PRL—systemic lupus erythematosus	0.000499	0.00139	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.000495	0.00138	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000493	0.00138	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—C3—systemic lupus erythematosus	0.000491	0.00137	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.000489	0.00137	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PRL—systemic lupus erythematosus	0.000478	0.00133	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—F2—systemic lupus erythematosus	0.000474	0.00132	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.000469	0.00131	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000469	0.00131	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—F2—systemic lupus erythematosus	0.000467	0.0013	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—JUNB—systemic lupus erythematosus	0.00046	0.00128	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.000444	0.00124	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000437	0.00122	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000433	0.00121	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—F2—systemic lupus erythematosus	0.000431	0.0012	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.000426	0.00119	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000425	0.00119	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PRL—systemic lupus erythematosus	0.000424	0.00118	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.000416	0.00116	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.000407	0.00114	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000404	0.00113	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—JAK1—systemic lupus erythematosus	0.000399	0.00111	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PRL—systemic lupus erythematosus	0.000391	0.00109	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.00039	0.00109	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.000384	0.00107	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—JAK1—systemic lupus erythematosus	0.000383	0.00107	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCR5—systemic lupus erythematosus	0.000378	0.00105	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.000378	0.00105	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.000373	0.00104	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL2—systemic lupus erythematosus	0.00037	0.00103	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—C3—systemic lupus erythematosus	0.000369	0.00103	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCR5—systemic lupus erythematosus	0.000362	0.00101	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.000357	0.000997	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL2—systemic lupus erythematosus	0.000355	0.000989	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—C3—systemic lupus erythematosus	0.000354	0.000988	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.000349	0.000973	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.000346	0.000966	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—JAK1—systemic lupus erythematosus	0.000339	0.000946	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—F2—systemic lupus erythematosus	0.000324	0.000905	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCR5—systemic lupus erythematosus	0.000321	0.000897	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.00032	0.000891	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.000317	0.000884	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL2—systemic lupus erythematosus	0.000314	0.000877	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—C3—systemic lupus erythematosus	0.000314	0.000876	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—JAK1—systemic lupus erythematosus	0.000313	0.000873	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—F2—systemic lupus erythematosus	0.000311	0.000868	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CD80—systemic lupus erythematosus	0.000311	0.000868	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CD80—systemic lupus erythematosus	0.000298	0.000832	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCR5—systemic lupus erythematosus	0.000297	0.000828	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.000292	0.000816	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL2—systemic lupus erythematosus	0.00029	0.00081	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—C3—systemic lupus erythematosus	0.00029	0.000809	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCL2—systemic lupus erythematosus	0.000289	0.000807	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCL2—systemic lupus erythematosus	0.000277	0.000773	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—F2—systemic lupus erythematosus	0.000276	0.000769	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CD80—systemic lupus erythematosus	0.000264	0.000738	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TYK2—systemic lupus erythematosus	0.000263	0.000732	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NOS3—systemic lupus erythematosus	0.000258	0.000719	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—F2—systemic lupus erythematosus	0.000255	0.00071	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TYK2—systemic lupus erythematosus	0.000252	0.000702	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NOS3—systemic lupus erythematosus	0.000247	0.000689	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCL2—systemic lupus erythematosus	0.000246	0.000686	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CD80—systemic lupus erythematosus	0.000244	0.000681	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCL2—systemic lupus erythematosus	0.000227	0.000633	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TYK2—systemic lupus erythematosus	0.000223	0.000623	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	0.000223	0.000623	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NOS3—systemic lupus erythematosus	0.000219	0.000611	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL2—systemic lupus erythematosus	0.000218	0.000609	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL6—systemic lupus erythematosus	0.000217	0.000606	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	0.000214	0.000597	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL2—systemic lupus erythematosus	0.000209	0.000584	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL6—systemic lupus erythematosus	0.000208	0.000581	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MMP9—systemic lupus erythematosus	0.000207	0.000577	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	0.000206	0.000575	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TYK2—systemic lupus erythematosus	0.000206	0.000575	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NOS3—systemic lupus erythematosus	0.000202	0.000564	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MMP9—systemic lupus erythematosus	0.000198	0.000553	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	0.000197	0.000551	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EP300—systemic lupus erythematosus	0.000196	0.000547	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDKN1B—systemic lupus erythematosus	0.00019	0.00053	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EP300—systemic lupus erythematosus	0.000188	0.000524	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL2—systemic lupus erythematosus	0.000186	0.000518	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—VEGFA—systemic lupus erythematosus	0.000186	0.000518	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL6—systemic lupus erythematosus	0.000185	0.000516	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	0.000178	0.000497	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MMP9—systemic lupus erythematosus	0.000176	0.00049	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	0.000175	0.000489	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	0.000175	0.000489	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL2—systemic lupus erythematosus	0.000171	0.000478	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL6—systemic lupus erythematosus	0.000171	0.000476	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TGFB1—systemic lupus erythematosus	0.00017	0.000475	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EP300—systemic lupus erythematosus	0.000167	0.000465	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	0.000163	0.000456	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MMP9—systemic lupus erythematosus	0.000162	0.000453	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	0.000162	0.000451	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—VEGFA—systemic lupus erythematosus	0.000158	0.00044	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EP300—systemic lupus erythematosus	0.000154	0.000429	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—VEGFA—systemic lupus erythematosus	0.000146	0.000406	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TGFB1—systemic lupus erythematosus	0.000145	0.000404	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TGFB1—systemic lupus erythematosus	0.000134	0.000373	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6—systemic lupus erythematosus	0.000128	0.000358	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6—systemic lupus erythematosus	0.000123	0.000343	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6—systemic lupus erythematosus	0.000109	0.000305	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6—systemic lupus erythematosus	0.000101	0.000281	CbGpPWpGaD
